Evidence map›Paper›PMID 27869123›Full record

ArticleNature communications2016

A systems study reveals concurrent activation of AMPK and mTOR by amino acids.

Piero Dalle Pezze, Stefanie Ruf, Annika G Sonntag, Miriam Langelaar-Makkinje, Philip Hall, Alexander M Heberle, Patricia Razquin Navas, Karen van Eunen, Regine C Tölle, Jennifer J Schwarz and 10 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed, 2 pooled it
19.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 2 syntheses or guidelines pooled it, 444 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Microglia-targetedMaterials today. Bio · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Long noncoding RNAs regulating enzymatic reactions in cancer.Experimental & molecular medicine · 2025
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 3 countries.

Piero Dalle PezzeInstitute for Cell and Molecular Biosciences (ICaMB), Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Stefanie RufDepartment of Bioinformatics and Molecular Genetics (Faculty of Biology), Institute for Biology 3, Albert-Ludwigs-University Freiburg, 79104 Freiburg, Germany.
Annika G SonntagDepartment of Bioinformatics and Molecular Genetics (Faculty of Biology), Institute for Biology 3, Albert-Ludwigs-University Freiburg, 79104 Freiburg, Germany.
Miriam Langelaar-MakkinjeDepartment of Pediatrics, University of Groningen, University Medical Center Groningen (UMCG), 9713 AV Groningen, The Netherlands.
Philip HallInstitute for Cell and Molecular Biosciences (ICaMB), Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Alexander M HeberleDepartment of Pediatrics, University of Groningen, University Medical Center Groningen (UMCG), 9713 AV Groningen, The Netherlands.
Patricia Razquin NavasDepartment of Pediatrics, University of Groningen, University Medical Center Groningen (UMCG), 9713 AV Groningen, The Netherlands.
Karen van EunenDepartment of Pediatrics, University of Groningen, University Medical Center Groningen (UMCG), 9713 AV Groningen, The Netherlands.
Regine C TölleDepartment of Bioinformatics and Molecular Genetics (Faculty of Biology), Institute for Biology 3, Albert-Ludwigs-University Freiburg, 79104 Freiburg, Germany.
Jennifer J SchwarzDepartment of Bioinformatics and Molecular Genetics (Faculty of Biology), Institute for Biology 3, Albert-Ludwigs-University Freiburg, 79104 Freiburg, Germany.
Heike WieseDepartment of Biochemistry and Functional Proteomics, Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany.ORCID 0000-0002-8941-3762
Bettina WarscheidSpemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, 79104 Freiburg, Germany.
Jana DeitersenInstitute of Molecular Medicine I, Medical Faculty, Heinrich-Heine-University, 40225 Düsseldorf, Germany.
Björn StorkInstitute of Molecular Medicine I, Medical Faculty, Heinrich-Heine-University, 40225 Düsseldorf, Germany.
Erik FäßlerJena University Language &Information Engineering (JULIE) Lab, Friedrich-Schiller-University Jena, 07743 Jena, Germany.
Sascha SchäubleJena University Language &Information Engineering (JULIE) Lab, Friedrich-Schiller-University Jena, 07743 Jena, Germany.
Udo HahnJena University Language &Information Engineering (JULIE) Lab, Friedrich-Schiller-University Jena, 07743 Jena, Germany.
Peter HorvatovichFaculty of Mathematics and Natural Sciences, Department of Pharmacy, Analytical Biochemistry, University of Groningen, 9713 AV Groningen, The Netherlands.
Daryl P ShanleyInstitute for Cell and Molecular Biosciences (ICaMB), Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Kathrin ThedieckDepartment of Pediatrics, University of Groningen, University Medical Center Groningen (UMCG), 9713 AV Groningen, The Netherlands.
University of Freiburg · DEUniversity Medical Center Groningen · NLFriedrich Schiller University Jena · DECarl von Ossietzky Universität Oldenburg · DEHeinrich Heine University Düsseldorf · DENewcastle Hospitals - Campus for Ageing and Vitality · GBBabraham Institute · GBUniversity of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amino acids (aa) are not only building blocks for proteins, but also signalling molecules, with the mammalian target of rapamycin complex 1 (mTORC1) acting as a key mediator. However, little is known about whether aa, independently of mTORC1, activate other kinases of the mTOR signalling network. To delineate aa-stimulated mTOR network dynamics, we here combine a computational-experimental approach with text mining-enhanced quantitative proteomics. We report that AMP-activated protein kinase (AMPK), phosphatidylinositide 3-kinase (PI3K) and mTOR complex 2 (mTORC2) are acutely activated by aa-readdition in an mTORC1-independent manner. AMPK activation by aa is mediated by Ca

Indexed as

Amino AcidsAMP-Activated Protein KinasesAutophagy-Related Protein-1 HomologCalcium-Calmodulin-Dependent Protein Kinase KinaseCell LineGene Expression RegulationHumansIntracellular Signaling Peptides and ProteinsMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2Models, BiologicalPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesAmino AcidsAMP-Activated Protein KinasesAutophagy-Related Protein-1 HomologCalcium-Calmodulin-Dependent Protein Kinase KinaseIntracellular Signaling Peptides and ProteinsMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2MTOR protein, humanPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesULK1 protein, human

Identifiers

PMID27869123
PMCPMC5121333
OpenAlexW2550846703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.